quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:01:46·10d
INSIDERFiling
Xencor Inc. logo

SEC Form 4 filed by Cornelissen Bart Jan

XNCR· Xencor Inc.
Health Care
Original source

Companies

  • XNCR
    Xencor Inc.
    Health Care

Recent analyst ratings

  • Mar 24UpdateAnalyst$13.00
  • Nov 24UpdateTruist-
  • Oct 29UpdateBarclays$23.00
  • Sep 17UpdateBarclays$6.00
  • Sep 3UpdateBofA Securities$12.00
  • Apr 21UpdateWilliam Blair-

Related

  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Xencor Inc.
  • ANALYST30d
    Xencor downgraded by Analyst with a new price target
  • INSIDER45d
    SR. VICE PRESIDENT & CSO Desjarlais John R sold $73,880 worth of shares (6,620 units at $11.16), decreasing direct ownership by 2% to 263,831 units (SEC Form 4)
  • INSIDER45d
    SVP, GENERAL COUNSEL Eckert Celia sold $55,952 worth of shares (5,011 units at $11.17), decreasing direct ownership by 6% to 76,918 units (SEC Form 4)
  • INSIDER45d
    SR. VICE PRESIDENT & CFO Cornelissen Bart Jan sold $28,305 worth of shares (2,517 units at $11.25), decreasing direct ownership by 3% to 79,397 units (SEC Form 4)
  • INSIDER45d
    PRESIDENT & CEO Dahiyat Bassil I sold $240,017 worth of shares (21,476 units at $11.18), decreasing direct ownership by 4% to 546,316 units (SEC Form 4)
  • SEC45d
    Xencor Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement
  • SEC48d
    SEC Form 144 filed by Xencor Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022